Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12663237rdf:typepubmed:Citationlld:pubmed
pubmed-article:12663237lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:12663237lifeskim:mentionsumls-concept:C0681867lld:lifeskim
pubmed-article:12663237lifeskim:mentionsumls-concept:C0033497lld:lifeskim
pubmed-article:12663237lifeskim:mentionsumls-concept:C0288171lld:lifeskim
pubmed-article:12663237lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:12663237lifeskim:mentionsumls-concept:C0162523lld:lifeskim
pubmed-article:12663237lifeskim:mentionsumls-concept:C0392756lld:lifeskim
pubmed-article:12663237lifeskim:mentionsumls-concept:C1707455lld:lifeskim
pubmed-article:12663237lifeskim:mentionsumls-concept:C0443252lld:lifeskim
pubmed-article:12663237pubmed:issue4lld:pubmed
pubmed-article:12663237pubmed:dateCreated2003-3-28lld:pubmed
pubmed-article:12663237pubmed:abstractTextThe role of angiotensin II (AT-II) type I receptor antagonists in the treatment of portal hypertension remains controversial. We tested the efficacy of Irbesartan (Irb) vs. Propranolol (Pro) in reducing portal pressure and evaluated its systemic haemodynamic effects.lld:pubmed
pubmed-article:12663237pubmed:languageenglld:pubmed
pubmed-article:12663237pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12663237pubmed:citationSubsetIMlld:pubmed
pubmed-article:12663237pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12663237pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12663237pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12663237pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12663237pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12663237pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12663237pubmed:statusMEDLINElld:pubmed
pubmed-article:12663237pubmed:monthAprlld:pubmed
pubmed-article:12663237pubmed:issn0168-8278lld:pubmed
pubmed-article:12663237pubmed:authorpubmed-author:RizzettoMario...lld:pubmed
pubmed-article:12663237pubmed:authorpubmed-author:LeoneNicolaNlld:pubmed
pubmed-article:12663237pubmed:authorpubmed-author:BarlettiClaud...lld:pubmed
pubmed-article:12663237pubmed:authorpubmed-author:TodrosLucaLlld:pubmed
pubmed-article:12663237pubmed:authorpubmed-author:SaraccoGiorgi...lld:pubmed
pubmed-article:12663237pubmed:authorpubmed-author:FaddaMaurizio...lld:pubmed
pubmed-article:12663237pubmed:authorpubmed-author:BaronioMonica...lld:pubmed
pubmed-article:12663237pubmed:authorpubmed-author:VenonWilma...lld:pubmed
pubmed-article:12663237pubmed:authorpubmed-author:RolfoElioElld:pubmed
pubmed-article:12663237pubmed:issnTypePrintlld:pubmed
pubmed-article:12663237pubmed:volume38lld:pubmed
pubmed-article:12663237pubmed:ownerNLMlld:pubmed
pubmed-article:12663237pubmed:authorsCompleteYlld:pubmed
pubmed-article:12663237pubmed:pagination455-60lld:pubmed
pubmed-article:12663237pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:12663237pubmed:meshHeadingpubmed-meshheading:12663237...lld:pubmed
pubmed-article:12663237pubmed:meshHeadingpubmed-meshheading:12663237...lld:pubmed
pubmed-article:12663237pubmed:meshHeadingpubmed-meshheading:12663237...lld:pubmed
pubmed-article:12663237pubmed:meshHeadingpubmed-meshheading:12663237...lld:pubmed
pubmed-article:12663237pubmed:meshHeadingpubmed-meshheading:12663237...lld:pubmed
pubmed-article:12663237pubmed:meshHeadingpubmed-meshheading:12663237...lld:pubmed
pubmed-article:12663237pubmed:meshHeadingpubmed-meshheading:12663237...lld:pubmed
pubmed-article:12663237pubmed:meshHeadingpubmed-meshheading:12663237...lld:pubmed
pubmed-article:12663237pubmed:meshHeadingpubmed-meshheading:12663237...lld:pubmed
pubmed-article:12663237pubmed:meshHeadingpubmed-meshheading:12663237...lld:pubmed
pubmed-article:12663237pubmed:meshHeadingpubmed-meshheading:12663237...lld:pubmed
pubmed-article:12663237pubmed:meshHeadingpubmed-meshheading:12663237...lld:pubmed
pubmed-article:12663237pubmed:meshHeadingpubmed-meshheading:12663237...lld:pubmed
pubmed-article:12663237pubmed:meshHeadingpubmed-meshheading:12663237...lld:pubmed
pubmed-article:12663237pubmed:meshHeadingpubmed-meshheading:12663237...lld:pubmed
pubmed-article:12663237pubmed:meshHeadingpubmed-meshheading:12663237...lld:pubmed
pubmed-article:12663237pubmed:year2003lld:pubmed
pubmed-article:12663237pubmed:articleTitleEffects of long-term Irbesartan in reducing portal pressure in cirrhotic patients: comparison with propranolol in a randomised controlled study.lld:pubmed
pubmed-article:12663237pubmed:affiliationDepartment of Gastroenterology, Ospedale Molinette, S. Giovanni Battista Hospital, C.so Bramante 88, 10126, Turin, Italy. wilmadebernardi@yahoo.itlld:pubmed
pubmed-article:12663237pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12663237pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:12663237pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:12663237pubmed:publicationTypeRandomized Controlled Triallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12663237lld:pubmed